Order Entry
United States
ContactUsLinkComponent
Human Recombinant TACI (from HEK293)
Human Recombinant TACI (from HEK293)
Supplier:  ACRO Biosystems
Certificates
Human Recombinant TACI (from HEK293)
Supplier:  ACRO Biosystems

Specifications

  • Protein/Peptide Type:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Storage Conditions:
    –20 °C
  • Endotoxin Content:
    Less than 1.0 EU per μg by the LAL method.
  • Biological Activity:
    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.; Measured by its binding ability in a functional ELISA. Immobilized Human BAFF, Fc Tag (Cat. No. BAF-H4268) at 2 μg/mL (100 μL/well) can bind Biotinylated Human TACI, Fc,Avitag (Cat. No. TAI-H82F6) with a linear range of 1.2-39 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilized Human APRIL, Fc Tag (Cat. No. APL-H5267) at 5 μg/mL (100 μL/well) can bind Biotinylated Human TACI, Fc,Avitag (Cat. No. TAI-H82F6) with a linear range of 0.01-0.313 μg/mL (Routinely tested).
  • Gene ID:
    O14836-1
  • Carrier-Free:
    Y
  • Protease-free:
    Y
  • Animal-Free:
    Y
  • Protein Synonyms:
    CD267|TNFRSF13B|TACI
  • Protein/Peptide Name:
    TACI
  • Purity:
    >90%
  • Molecular Weight:
    46.7 kDa
  • Endotoxin Level:
    Low
  • Formulation:
    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
  • Nuclease-free:
    Y
  • Shipping Temperature:
    Powder,RT

Specifications

Frequently Bought Together